Information:
Error:
ID
16005
Description
The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain; ODM derived from: https://clinicaltrials.gov/show/NCT00188669
Link
https://clinicaltrials.gov/show/NCT00188669
Keywords
Versions (2)
- 5/5/16 5/5/16 -
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT00188669
Eligibility Breast Neoplasms NCT00188669
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT00188669
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
breast cancer tnm stage
Item
uicc tnm stage 0 (i.e. in situ disease), 1 or 2 breast cancer patients treated with conservative surgery and adjuvant radiotherapy with chronic breast pain or tenderness, with or without fibrosis, within 3 months to 3 years following completion of radiotherapy
boolean
C0150055 (UMLS CUI [1])
C0234233 (UMLS CUI [2])
C0234233 (UMLS CUI [2])
age
Item
age 18 to 75 years of age
boolean
C0001779 (UMLS CUI [1])
chronic symptoms like pain, tenderness, fibrosis, necrosis or ulceration
Item
chronic symptoms localised to the breast treated with radiation, i.e. any one or more of the following- pain (not attributable to infection) or tenderness with or without associated oedema, fibrosis, necrosis or ulceration.
boolean
C0156323 (UMLS CUI [1])
breast pain
Item
breast pain (maximum in the previous 24 hours) measurable on a linear analogue scale with a length of 3cm or greater
boolean
C0024902 (UMLS CUI [1])
prior radiation therapy
Item
prior treatment with radiation to the affected area i.e. in tangential breast fields or boost area
boolean
C1522449 (UMLS CUI [1])
radiation completed
Item
radiation completed at least 3 months and no longer than 3 years prior to study entry
boolean
C0011008 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
informed consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Cellulitis of breast
Item
active cellulitis in the breast
boolean
C0392003 (UMLS CUI [1])
Malignant Neoplasms
Item
active malignant disease
boolean
C0006826 (UMLS CUI [1])
comorbidity not influencing protocol treatment
Item
any medical illness or condition judged likely by the local investigator to preclude safe administration of protocol treatment
boolean
C0009488 (UMLS CUI [1])
contraindication to pentoxifylline
Item
contraindication to treatment with pentoxifylline (i.e. previously exhibited intolerance to pentoxifylline or other xanthines such as caffeine, theophylline or theobromine; recent cerebral and/or retinal haemorrhage; ischaemic heart disease; hypotension
boolean
C1301624 (UMLS CUI [1,1])
C0030899 (UMLS CUI [1,2])
C0030899 (UMLS CUI [1,2])
pregnant or lactating
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])